Establishment Labs Holdings, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VGG312491084
USD
70.71
3.23 (4.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Establishment Labs Holdings, Inc. stock-summary
stock-summary
Establishment Labs Holdings, Inc.
Pharmaceuticals & Biotechnology
Establishment Labs Holdings Inc. is a medical technology and aesthetics company that is focused on patient safety and aesthetic outcomes and also in the breast aesthetics and reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. Its line of silicone gel-filled breast implants, branded as MotivaImplants, is the centerpiece of its MotivaImagine medical technology platform. The Company’s MotivaImplants are sold in over 60 countries.
Company Coordinates stock-summary
Company Details
Building B15 and 25, Coyol Free Zone , ALAJUELA None : VG1110
stock-summary
Tel: 506 2 43424001 949 4476671
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 29 Schemes (12.72%)

Foreign Institutions

Held by 63 Foreign Institutions (11.56%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Nicholas Lewin
Chairman of the Board
Mr. Juan Jose Chacon Quiros
Chief Executive Officer, Director
Ms. Lisa Colleran
Independent Director
Mr. Dennis Condon
Independent Director
Ms. Lisa Gersh
Independent Director
Dr. David Hung
Independent Director
Mr. Edward Schutter
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
51 Million
(Quarterly Results - Jun 2025)
Net Profit:
-17 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 1,124 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

7.60

stock-summary
Return on Equity

-388.86%

stock-summary
Price to Book

49.36